. 2020 Feb 28;18(2):86–95. doi: 10.1089/met.2019.0086

Table 2.

Overall Prevalence of Metabolic Syndrome in Accordance with Sociodemographic Characteristics

	Total	MS prevalence
	n	n	% (95% CI)
Total^a	1032	102	9.9 (8.1–11.7)
Mexico	316	22	7.0 (4.1–9.8)
Colombia	285	37	13.0 (9.1–16.9)
Brazil	223	11	4.9 (2.1–7.8)
Paraguay	132	30	22.7 (15.5–30.0)
Argentina	76	2	2.6 (0.3–9.2)
Sex^a
Male	290	52	17.9 (13.5–22.3)
Female	742	50	6.7 (4.9–8.5)
Age (years)^a,b
≤28	693	38	5.5 (3.8–7.2)
≥29	339	64	18.9 (14.7–23.1)
Occupational status
Student	572	38	6.6 (4.6–8.7)
Professional	460	64	13.9 (10.7–17.1)
Health sector^a
Nutrition	351	11	3.1 (1.3–5.0)
Medicine	237	43	18.1 (13.2–23.1)
Nursing	134	19	14.2 (8.2–20.2)
Other areas	307	29	9.4 (6.2–12.7)
BMI^a,b
Normal weight	716	11	1.5 (0.6–2.4)
Overweight-obese	316	91	28.8 (23.8–33.8)
Smoking status^b
Nonsmoker	940	91	9.7 (7.8–11.6)
Smoker	76	10	13.2 (5.4–20.9)
PA (min/week)^c
<150	57	11	19.3 (8.7–29.9)
>150	975	91	9.3 (7.5–11.2)
PA energy expenditure (kcal/day)^b
≤596	688	70	10.2 (7.9–12.4)
≥597	344	32	9.3 (6.2–12.4)

Presence of three or more of the following risk factors: AO, high-BP, high-FPG, high-TG, or low HDL-C (medication for one of these conditions should be included as a criterion, even when the measurements taken show adequate values). The total n in the variable “smoking status” is 1016 and the total n in the variable “health sector” is 1029. The prevalence rates reported in this table are not standardized by age. Data are expressed as numbers (n), percentages (%), and 95% CI. Comparisons between proportions were calculated using the chi-square or Fisher's exact test, in accordance with testing conditions.

^{^a}

P < 0.001.

^{^b}

Variables were recategorized into two categories due to the low frequency of MS in some categories.

^{^c}

P < 0.05.

AO, abdominal obesity; BP, blood pressure; CI, confidence interval; high-TG, hypertriglyceridemia; MS, metabolic syndrome.